The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Pharmacology
(Nov 2021)
Topical Insights Into the Post-Approval Controversies of Aducanumab
Dhiraj Kumar,
Dharmendra Kumar Yadav,
Md Imtaiyaz Hassan
Affiliations
Dhiraj Kumar
Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India
Dharmendra Kumar Yadav
College of Pharmacy, Gachon University of Medicine and Science, Incheon, South Korea
Md Imtaiyaz Hassan
Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India
DOI
https://doi.org/10.3389/fphar.2021.787303
Journal volume & issue
Vol. 12
Abstract
Read online
No abstracts available.
Keywords
Alzheimer’s drug
Aducanumab
Neurodegenerative diseases
FDA—Food and drug administration
Neuropsychological
WeChat QR code
Close